A Study to Assess the Safety & Efficacy of Elezanumab When Added to

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05177523` - Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Not yet recruiting	`NCT06053749` - An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
Not yet recruiting	`NCT06450600` - Enhancing Quality of Life in MS Patients Through Tailored Therapeutic Education	N/A
Recruiting	`NCT04926818` - Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis	Phase 3
Not yet recruiting	`NCT03624296` - Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study	N/A
Terminated	`NCT04203498` - Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis	Phase 3
Active, not recruiting	`NCT04602390` - Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis	Phase 1
Completed	`NCT01804647` - Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Terminated	`NCT04907305` - Next-Gen MS: Feed-forward PRO Data for MS Research
Active, not recruiting	`NCT03456206` - Chronic Inflammatory Disease, Lifestyle and Risk of Disease
Completed	`NCT04705610` - Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography	N/A
Completed	`NCT01366027` - PRISM Registry: Pseudobulbar Affect Registry Series	N/A
Completed	`NCT03135249` - Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis	Phase 4
Recruiting	`NCT05633875` - Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
Completed	`NCT02612935` - An Observational Pilot Study of Lumosity Computerized Cognitive Training in Subjects With Multiple Sclerosis	N/A
Completed	`NCT02739542` - Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)	Phase 4
Completed	`NCT03177655` - Effect of Guided Imagery on Well-being in Patients With Multiple Sclerosis	N/A
Active, not recruiting	`NCT04777539` - Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Recruiting	`NCT02352194` - Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis	N/A
Completed	`NCT02308579` - Centralized Reading Assessment of Chronic CerebroSpinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis and Other Neurological Diseases	N/A

NCT number	NCT03737851
Study type	Interventional
Source	AbbVie
Contact
Status	Completed
Phase	Phase 2
Start date	December 11, 2018
Completion date	September 9, 2021

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms